Inheritance Patterns in Pedigrees

A pedigree is a diagram of matings and offspring across generations, using standardized symbols (Pedigree Symbols and Construction): squares for males, circles for females, filled symbols for affected individuals, horizontal lines for matings, and vertical lines dropping to offspring. Reading a pedigree for mode of inheritance means asking a small set of diagnostic questions: Does the trait appear in every generation, or does it skip? Are males and females affected in roughly equal numbers? Do two unaffected parents ever produce an affected child? Does an affected father ever pass the trait to a son? The logic connecting these observations to chromosomal location rests entirely on how alleles segregate at meiosis and how Genotype, Phenotype, and Dominance translates genotype into visible phenotype. Autosomal loci sit on one of the 22 non-sex chromosome pairs, present in two copies in both sexes, so autosomal traits show no inherent sex bias. X-linked loci sit on the X chromosome, of which males (XY) have only one copy and females (XX) have two — this asymmetry is the entire reason X-linked pedigrees look different from autosomal ones. Dominance determines whether one or two copies of the disease allele are needed to produce the phenotype, which in turn determines whether a trait appears in every generation (dominant) or skips generations, hiding in heterozygous carriers (recessive). Four canonical patterns are taught as idealized types, and real pedigrees are compared against these templates: autosomal dominant (AD), autosomal recessive (AR), X-linked recessive (XLR), and X-linked dominant (XLD). Y-linked (holandric) inheritance is a fifth, rarer pattern — transmitted from father to all sons and never to daughters — relevant to a handful of loci in the male-specific region of the Y chromosome. Mitochondrial inheritance, transmitted only through mothers to all offspring, is a related but non-Mendelian pattern often introduced alongside these four. Each pattern is a hypothesis to be tested against the specific pedigree at hand, not a rigid law — a single small family can be consistent with more than one mode, and definitive assignment often requires molecular confirmation.

Autosomal dominant (AD). The disease allele, conventionally written A, is dominant to the wild-type allele a. A single copy is sufficient to produce the phenotype, so affected individuals are typically heterozygous (Aa), because homozygous dominant (AA) is often rare or, for many severe conditions, inviable. Every affected individual has at least one affected parent, except in cases of a new mutation. Because the trait is expressed with just one copy on a non-sex chromosome, males and females are affected in equal proportions, and either sex can transmit the trait to either sex. An Aa × aa cross — the typical mating of an affected heterozygote to an unaffected homozygote — yields a 1:1 ratio of affected to unaffected offspring, generation after generation, so the trait appears to march straight down the pedigree without skipping.

Autosomal recessive (AR). The disease allele a is recessive; only homozygotes (aa) are affected. Heterozygotes (Aa) are unaffected carriers, phenotypically indistinguishable from homozygous normal (AA) individuals. Because carriers are silent, the trait can vanish from view for one or more generations and then reappear when two carriers happen to mate. The classic mating that reveals AR inheritance is Aa × Aa, which produces offspring in the ratio: ``` 1 AA : 2 Aa : 1 aa ``` — that is, on average one-quarter of the offspring are affected, and this quarter is realized only statistically across many families, not deterministically within one small sibship. Because the causative allele is recessive and homozygosity requires two copies drawn independently, AR conditions are markedly more frequent in the offspring of consanguineous matings (e.g., first cousins), since related individuals are more likely to carry the same rare allele inherited from a common ancestor.

X-linked recessive (XLR). The locus sits on the X chromosome; the disease allele is recessive. Because males are hemizygous (genotype X^A Y or X^a Y, only one X), a single copy of the recessive allele is sufficient to produce the phenotype in a male — there is no second X to mask it. Females need two copies (X^a X^a) to be affected, which is much rarer when the allele frequency is low. This asymmetry produces the signature excess of affected males in XLR pedigrees. A carrier mother (X^A X^a) transmits the disease allele to half her sons (who are affected) and half her daughters (who become carriers), even though she herself shows no phenotype. An affected father (X^a Y) transmits his X only to daughters, who all become carriers (assuming the mother is X^A X^A); he never transmits the trait to a son, because sons receive his Y chromosome, not his X. This absence of father-to-son transmission is the single most powerful diagnostic clue for X-linkage.

X-linked dominant (XLD). The disease allele is dominant, so a single copy on the X produces the phenotype in either sex. Affected heterozygous females (X^A X^a) transmit the trait to half their sons and half their daughters — resembling autosomal dominant inheritance in this respect. But an affected hemizygous father (X^A Y) transmits the trait to all of his daughters (who receive his X^A) and none of his sons (who receive his Y) — a stark and diagnostic 100%-versus-0% split that never occurs in autosomal dominant inheritance. XLD conditions are relatively rare among classical human pedigree examples; hypophosphatemic rickets (vitamin D–resistant rickets) is a commonly cited case.

Y-linked (holandric). Genes in the male-specific region of the Y chromosome pass from father to every son and to no daughters, producing a pedigree in which the trait tracks the male line exclusively, generation after generation, with no exceptions and no transmission through females at all.

Pedigree analysis is unusual among the classic proofs of genetics in that it did not arise from a single decisive laboratory experiment like Meselson-Stahl or Hershey–Chase. Instead, the modes of inheritance were established by the cumulative, quantitative study of many human families, cross-checked against Mendelian ratios derived from experimental organisms. Three historical threads are worth tracing explicitly.

Archibald Garrod and alkaptonuria (1902). The British physician Archibald Garrod studied alkaptonuria, a rare condition in which urine turns black on exposure to air, due to accumulation of homogentisic acid. Garrod noticed something the medical literature of the time found puzzling: the condition frequently appeared in siblings whose parents were entirely unaffected, and it was strikingly overrepresented in the children of first-cousin marriages. Garrod consulted the biologist William Bateson, one of the first champions of Mendel's rediscovered laws in Britain. Bateson recognized that Garrod's pedigrees matched exactly the pattern expected of a rare recessive trait: unaffected heterozygous carrier parents (Aa × Aa), each carrying one copy of a rare defective allele, producing an affected child with probability 1/4 — invisible in the parents, visible in the offspring, and enriched by consanguinity because relatives are more likely to share the same rare allele by descent. Garrod's 1902 paper on alkaptonuria is now recognized as the first application of Mendelian recessive inheritance to a specific human disease, and the conceptual origin of "inborn errors of metabolism."

Julia Bell and J. B. S. Haldane, hemophilia in Queen Victoria's descendants (1930s). Hemophilia A, a blood-clotting disorder, appeared in explosive and geographically dispersed fashion among the royal houses of Europe descended from Queen Victoria — sons of her daughters and granddaughters were affected, but her own sons showed the trait only if their mother was a carrier, and affected men never transmitted the disease to their own sons. Bell and Haldane's statistical analysis of these documented royal pedigrees (compiled in their 1935 study of the genetics of hemophilia) confirmed the X-linked recessive pattern predicted from the sex-chromosome theory: Victoria herself, unaffected, was an obligate carrier (X^A X^a), presumably from a new mutation in herself or a parent's germline, since no prior family history was documented. Her carrier daughters transmitted the allele onward, her affected sons (Leopold) never transmitted it to their own sons, and the disease appeared explosively across the crowned families of Russia, Spain, and Germany precisely following the segregation rules of an X-linked recessive allele. This pedigree remains the most famous illustration of X-linked recessive inheritance in any textbook, precisely because royal marriage records provided an unusually complete, verifiable multigenerational dataset — a rarity in human genetics, where families are typically far too small to establish a pattern from a single lineage alone.

Curt Stern and the chromosomal basis of sex-linkage (1931). While pedigrees showed the statistical signature of X-linkage, definitive physical proof that genes for X-linked traits actually reside on the X chromosome came from Drosophila cytogenetics. Building on Thomas Hunt Morgan's 1910 discovery of the white-eye mutation's sex-linked transmission pattern in fruit flies, Curt Stern (and, independently, Harriet Creighton and Barbara McClintock in maize the same year) demonstrated that recombination of a genetic trait was always accompanied by physical exchange of a cytologically visible, structurally marked chromosome segment. Stern used flies with an X chromosome that had an abnormal, microscopically distinguishable shape; when recombination between two linked genes occurred, the visible chromosome marker recombined right along with the genes. This proved that genes are physically located on chromosomes and segregate with them — the crucial link between the statistical pattern seen in pedigrees (X-linkage) and the physical chromosome (the X) that pedigrees implicate. Morgan's original white-eye cross is itself instructive: a white-eyed male fly crossed to a red-eyed (wild-type) female produced all red-eyed F1 offspring of both sexes, but the F2 generation showed white eyes only in males — the reciprocal cross (white-eyed female × red-eyed male) gave a completely different result, with white-eyed offspring of both sexes, revealing that the trait's transmission depended on the sex of the parent carrying it, exactly as expected if the gene resides on the X chromosome.

Example 1 — distinguishing AR from XLR in a real-shaped family. Consider a pedigree: Generation I has an unaffected woman (I-2) married into the family, and an unaffected man (I-1) with no family history of disease. They have four children in Generation II: two unaffected daughters (II-1, II-3) and two sons, one affected (II-2) and one unaffected (II-4). II-1 (unaffected daughter) marries an unaffected outside man (II-5, no family history) and they have three children in Generation III: one affected son (III-1), one unaffected son (III-2), and one unaffected daughter (III-3). No females are affected anywhere in the pedigree, across three generations and seven total offspring. Step 1: Both parents in Generation I are unaffected, yet they produced an affected son. This rules out autosomal dominant (which requires an affected parent, barring new mutation) and is consistent with either autosomal recessive or X-linked recessive. Step 2: All affected individuals are male (II-2 and III-1), and no female across the entire pedigree is affected, despite four female individuals being at risk of inheriting the same underlying allele. If the trait were autosomal recessive, we would expect roughly equal odds of an aa daughter and an aa son, since both sexes carry two copies of the autosome — an exclusively male-affected pattern across seven offspring, while not statistically impossible, is a poor fit to a 50/50 sex-independent hypothesis. Step 3: Critically, II-1, an unaffected daughter of Generation I, has an affected son (III-1) despite marrying an unaffected, unrelated man (II-5) with no family history. This is the diagnostic signature of a carrier female: II-1 must be a heterozygous carrier (X^A X^a), having inherited the X^a allele from her father (I-1), who — although unaffected in the pedigree as drawn — would have to be hemizygous for a silently transmitted variant, or, more parsimoniously in many textbook versions of this pedigree, the mother I-2 is the carrier and I-1 is simply unaffected homozygous X^A Y. Step 4: Assigning I-2 as the carrier (X^A X^a) and I-1 as unaffected (X^A Y): their sons have a 1/2 chance of inheriting the maternal X^a and being affected — consistent with one affected, one unaffected son observed. Their daughters have a 1/2 chance of being carriers (X^A X^a) themselves, phenotypically normal — consistent with II-1 being a silent carrier who then produces an affected grandson through her own 1/2 transmission risk. Every observed data point — male-only expression, an unaffected carrier grandmother, an unaffected mother who nonetheless transmits the trait, and no father-to-son transmission — fits X-linked recessive inheritance precisely, and fits autosomal recessive poorly. Conclusion: X-linked recessive.

Example 2 — autosomal dominant with incomplete penetrance, and a numeric risk calculation. A family segregates a form of hereditary polydactyly (extra digits). The pedigree shows an affected grandfather (I-1), one of whose four children — a daughter, II-2 — is unaffected by exam, yet II-2 has an affected son (III-1) despite marrying an unaffected, unrelated man (II-3, no family history whatsoever). Naively, an unaffected parent (II-2) producing an affected child looks like recessive inheritance. But three other lines of evidence argue for autosomal dominant inheritance with incomplete penetrance: the trait is present in Generation I, Generation II (in two of the four siblings, not shown unaffected here), and Generation III; the condition affects males and females with equal frequency across the extended family records; and molecular testing (foreshadowing Pedigree Analysis, where such auxiliary data are formally incorporated) shows that II-2 in fact carries the disease allele, confirmed by finding the same variant in both her affected father and her affected son — she is a nonpenetrant carrier, someone who inherited and transmitted the dominant allele but did not express the phenotype, a phenomenon called incomplete penetrance. If the polydactyly allele in this family has an estimated penetrance of 70% (meaning 70% of individuals carrying the dominant allele actually show the trait), we can compute the probability that a phenotypically normal child of an affected parent is nonetheless a silent carrier: ``` P(carrier | unaffected) = P(unaffected | carrier) × P(carrier) / P(unaffected) ``` For an Aa × aa mating (affected heterozygous parent × unaffected homozygous parent), each child has a prior probability of 1/2 of inheriting the A allele (being a genetic carrier). Given 70% penetrance, a carrier child appears unaffected with probability 0.30. An unaffected phenotype in a child of this mating can therefore arise two ways: the child is a non-carrier (probability 1/2, always unaffected), or the child is a carrier who fails to express the trait (probability 1/2 × 0.30 = 0.15). The overall probability of appearing unaffected is 0.5 + 0.15 = 0.65. So: ``` P(carrier | unaffected) = 0.15 / 0.65 ≈ 0.23 (about 23%) ``` This means that roughly 23% of the phenotypically normal children of an affected parent in this family are actually silent carriers who could transmit the trait onward — exactly the situation observed with II-2. This calculation illustrates why incomplete penetrance is one of the most treacherous complications in reading pedigrees: it can make a true autosomal dominant trait masquerade as recessive by apparently "skipping" a generation.

Archibald Edward Garrod trained as a physician at Oxford and worked at St Bartholomew's Hospital in London, where his clinical fascination with rare metabolic curiosities — alkaptonuria, albinism, cystinuria, and pentosuria — led him to a radical idea for his time: that some diseases are not infections or environmental insults but permanent, inherited chemical variations in an individual's biochemistry, present from birth and transmitted according to Mendelian rules. Garrod's insight depended crucially on collaboration with William Bateson, who supplied the Mendelian statistical framework Garrod's clinical pedigrees needed. Garrod's 1908 Croonian Lectures, later expanded into the book Inborn Errors of Metabolism, established the entire conceptual lineage that runs from Mendelian pedigree analysis through to modern biochemical and molecular genetics — the idea that a single gene defect can cause a single specific enzymatic block, a concept later crystallized by George Beadle and Edward Tatum as "one gene, one enzyme."

Genetic counselors routinely construct three-generation pedigrees as the first step in any consult for a suspected inherited condition, using the signatures described here to generate a short list of candidate modes of inheritance before ordering any molecular test — a practice that dramatically narrows and speeds up genomic diagnosis. In reproductive medicine, recognizing an X-linked recessive pattern (as in Duchenne muscular dystrophy or hemophilia A and B) directly informs recurrence-risk counseling for future pregnancies and guides decisions about carrier testing for at-risk female relatives, prenatal diagnosis, or preimplantation genetic testing during IVF. In oncology, pedigree pattern recognition — an autosomal dominant signature of breast and ovarian cancer clustering across generations on one side of a family — is often the first clue prompting BRCA1/*BRCA2* testing, well before any sequencing occurs. In agriculture and animal breeding, the same logic of dominance and segregation guides breeders trying to eliminate recessive deleterious alleles from livestock or crop lines, often by identifying and culling carrier individuals revealed through pedigree records. In conservation genetics, pedigree-based inbreeding coefficients — an extension of the same consanguinity logic that flagged Garrod's alkaptonuria families — are used to manage captive breeding programs for endangered species, minimizing the risk of exposing rare deleterious recessive alleles through excessive relatedness among breeding pairs.

Ask the tutor: How do geneticists calculate exact recurrence-risk probabilities from an ambiguous pedigree, and how does Bayesian reasoning refine these estimates once molecular or carrier-test data become available?